LLY - Will Eli Lilly and Company Become A Trillion-Dollar Baby?

2024-02-08 11:57:41 ET

Summary

• Eli Lilly and Company stock has seen a 21.8% increase since the article was written, outperforming the S&P 500.
• The company's strong earnings growth and potential for blockbuster drugs contribute to its continued success.
• The 5-year target price for Eli Lilly has been raised to $1,318, indicating 81.8% upside potential over the next 3-5 years.

I last wrote about Eli Lilly and Company (LLY) back in a September 11, 2023 article . At that time, the stock was trading at $595.56 per share. I gave the stock a buy rating and put out a 5-year target price of $1,020 per share. During my 25 years as a professional money manager and analyst, I have always used 5-year target prices. It helps take a lot of short-term emotion out of the equation. In addition to this, why do analysts come up with 5-year growth rates and 6-month target prices? That makes no sense to me....

For further details see: